Anson Funds Management LP 13D/13G Filings for SELLAS Life Sciences Group, Inc. (SLS)

Anson Funds Management LP 13D and 13G filings for SELLAS Life Sciences Group, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-15
4:59 pm
Purchase
2025-03-3113GSELLAS Life Sciences Group, Inc.
SLS
Anson Funds Management LP7,579,095
8.300%
7,579,095increase
(New Position)
Filing